TARDBP and amyotrophic lateral sclerosis: Devlin and colleagues have shown that hPSC-derived MNs from ALS patients harbouring the C9ORF72 or TARDBP mutations demonstrate an initial hyperexcitability followed by hypoexcitability [106].